Stoke Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.About STOK
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver.
CEOIan Frederick Smith
CEOIan Frederick Smith
Employees128
Employees128
HeadquartersBedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded2014
Founded2014
Employees128
Employees128
STOK Key Statistics
Market cap721.77M
Market cap721.77M
Price-Earnings ratio15.70
Price-Earnings ratio15.70
Dividend yield—
Dividend yield—
Average volume523.02K
Average volume523.02K
High today$14.50
High today$14.50
Low today$12.49
Low today$12.49
Open price$12.93
Open price$12.93
Volume1.54M
Volume1.54M
52 Week high$16.15
52 Week high$16.15
52 Week low$5.35
52 Week low$5.35
STOK News
TipRanks 1d
Stoke Therapeutics’ EMPEROR Study: A New Hope for Dravet SyndromeStoke Therapeutics ((STOK)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% of...
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own STOK. This list is generated using Robinhood data, and it’s not a recommendation.